In particular, the combination of HSP70, ENO1 and RNH1 autoantibodies reactivities represent a good candidates as a new biomarker for CCA and should thus be investigated in a large-scale prospective study in high-risk subjects such as liver fluke infected Thai subjects. The gene discussed is RNH1; the disease is cholangiocarcinoma.